Report Detail
Global Niraparib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3557467 |
- 26 June, 2019 |
- Global |
- 107 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Scope of the Report:
The worldwide market for Niraparib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Niraparib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
TESARO
Everest Pharmaceuticals Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
Market Segment by Applications, can be divided into
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Niraparib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Niraparib, with price, sales, revenue and global market share of Niraparib in 2017 and 2018.
Chapter 3, the Niraparib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Niraparib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Niraparib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Niraparib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Niraparib Introduction
- 1.2 Market Analysis by Type
- 1.2.1 100mg*30 Capsules
- 1.2.2 100mg*60 Capsules
- 1.2.3 100mg*90 Capsules
- 1.3 Market Analysis by Applications
- 1.3.1 Recurrent Epithelial Ovarian Cancer
- 1.3.2 Fallopian Tube Cancer
- 1.3.3 Primary Peritoneal Cancer
- 1.3.4 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 TESARO
- 2.1.1 Business Overview
- 2.1.2 Niraparib Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Everest Pharmaceuticals Limited
- 2.2.1 Business Overview
- 2.2.2 Niraparib Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Niraparib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Niraparib Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Niraparib Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Niraparib Manufacturer Market Share in 2018
- 3.3.2 Top 6 Niraparib Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Niraparib Market Analysis by Regions
- 4.1 Global Niraparib Sales, Revenue and Market Share by Regions
- 4.1.1 Global Niraparib Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Niraparib Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Niraparib Sales and Growth Rate (2014-2019)
- 4.3 Europe Niraparib Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Niraparib Sales and Growth Rate (2014-2019)
- 4.5 South America Niraparib Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Niraparib Sales and Growth Rate (2014-2019)
5 North America Niraparib by Country
- 5.1 North America Niraparib Sales, Revenue and Market Share by Country
- 5.1.1 North America Niraparib Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Niraparib Revenue and Market Share by Country (2014-2019)
- 5.2 United States Niraparib Sales and Growth Rate (2014-2019)
- 5.3 Canada Niraparib Sales and Growth Rate (2014-2019)
- 5.4 Mexico Niraparib Sales and Growth Rate (2014-2019)
6 Europe Niraparib by Country
- 6.1 Europe Niraparib Sales, Revenue and Market Share by Country
- 6.1.1 Europe Niraparib Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Niraparib Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Niraparib Sales and Growth Rate (2014-2019)
- 6.3 UK Niraparib Sales and Growth Rate (2014-2019)
- 6.4 France Niraparib Sales and Growth Rate (2014-2019)
- 6.5 Russia Niraparib Sales and Growth Rate (2014-2019)
- 6.6 Italy Niraparib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Niraparib by Country
- 7.1 Asia-Pacific Niraparib Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Niraparib Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Niraparib Revenue and Market Share by Country (2014-2019)
- 7.2 China Niraparib Sales and Growth Rate (2014-2019)
- 7.3 Japan Niraparib Sales and Growth Rate (2014-2019)
- 7.4 Korea Niraparib Sales and Growth Rate (2014-2019)
- 7.5 India Niraparib Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Niraparib Sales and Growth Rate (2014-2019)
8 South America Niraparib by Country
- 8.1 South America Niraparib Sales, Revenue and Market Share by Country
- 8.1.1 South America Niraparib Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Niraparib Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Niraparib Sales and Growth Rate (2014-2019)
- 8.3 Argentina Niraparib Sales and Growth Rate (2014-2019)
- 8.4 Colombia Niraparib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Niraparib by Countries
- 9.1 Middle East and Africa Niraparib Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Niraparib Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Niraparib Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Niraparib Sales and Growth Rate (2014-2019)
- 9.3 Turkey Niraparib Sales and Growth Rate (2014-2019)
- 9.4 Egypt Niraparib Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Niraparib Sales and Growth Rate (2014-2019)
- 9.6 South Africa Niraparib Sales and Growth Rate (2014-2019)
10 Global Niraparib Market Segment by Type
- 10.1 Global Niraparib Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Niraparib Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Niraparib Revenue and Market Share by Type (2014-2019)
- 10.2 100mg*30 Capsules Sales Growth and Price
- 10.2.1 Global 100mg*30 Capsules Sales Growth (2014-2019)
- 10.2.2 Global 100mg*30 Capsules Price (2014-2019)
- 10.3 100mg*60 Capsules Sales Growth and Price
- 10.3.1 Global 100mg*60 Capsules Sales Growth (2014-2019)
- 10.3.2 Global 100mg*60 Capsules Price (2014-2019)
- 10.4 100mg*90 Capsules Sales Growth and Price
- 10.4.1 Global 100mg*90 Capsules Sales Growth (2014-2019)
- 10.4.2 Global 100mg*90 Capsules Price (2014-2019)
11 Global Niraparib Market Segment by Application
- 11.1 Global Niraparib Sales Market Share by Application (2014-2019)
- 11.2 Recurrent Epithelial Ovarian Cancer Sales Growth (2014-2019)
- 11.3 Fallopian Tube Cancer Sales Growth (2014-2019)
- 11.4 Primary Peritoneal Cancer Sales Growth (2014-2019)
- 11.5 Other Sales Growth (2014-2019)
12 Niraparib Market Forecast (2019-2024)
- 12.1 Global Niraparib Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Niraparib Market Forecast by Regions (2019-2024)
- 12.2.1 North America Niraparib Market Forecast (2019-2024)
- 12.2.2 Europe Niraparib Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Niraparib Market Forecast (2019-2024)
- 12.2.4 South America Niraparib Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Niraparib Market Forecast (2019-2024)
- 12.3 Niraparib Market Forecast by Type (2019-2024)
- 12.3.1 Global Niraparib Sales Forecast by Type (2019-2024)
- 12.3.2 Global Niraparib Market Share Forecast by Type (2019-2024)
- 12.4 Niraparib Market Forecast by Application (2019-2024)
- 12.4.1 Global Niraparib Sales Forecast by Application (2019-2024)
- 12.4.2 Global Niraparib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Niraparib . Industry analysis & Market Report on Niraparib is a syndicated market report, published as Global Niraparib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Niraparib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
